Company Reports (Pharma & Healthcare)


Company Reports (Pharma and Healthcare) Market Research Reports Analysis and Trends

The Company Reports in the Pharma and healthcare gives a comprehensive coverage on a various company's activities in the medical field.

In the Pharma and Healthcare company reports, it gives information on various companies in healthcare industry.

The Company reports, gives information on these topics.

  • Current developmental pipeline and latest updates of pharmaceutical companies.
  • Business description
  • Key information and facts
  • Major projects accomplished
  • Company’s location and their subsidiaries
  • Market share analysis
  • Research and development
  • Competitor’s in Pharma and healthcare industry
  • Prospects of the company
  • Shareholders and latest news on company products.

List of top 12 fortune 500 Pharma companies worldwide given by CNN Money are Pfizer, Johnson & Johnson, Merck, Abbot Laboratories, Eli Lilly, Bristol-Myers Squibb, Amgen, Gilead Sciences, Mylan, Allergan, Biogen Idec, and Celgene. 

Publication Single User License (PDF) Price
Exactech, Inc. (EXAC) - Product Pipeline Analysis, 2014 Update

Exactech, Inc. (EXAC) - Product Pipeline Analysis, 2014 Update

Date Published: Nov 14 2014

Summary

$750.00
Hansen Medical, Inc. (HNSN) - Product Pipeline Analysis, 2014 Update

Hansen Medical, Inc. (HNSN) - Product Pipeline Analysis, 2014 Update

Date Published: Nov 14 2014

Summary

$750.00
Johnson & Johnson Vision Care, Inc. - Product Pipeline Analysis, 2014 Update

Johnson & Johnson Vision Care, Inc. - Product Pipeline Analysis, 2014 Update

Date Published: Nov 14 2014

Summary

$750.00
Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2014 Update

Nanosphere, Inc. (NSPH) - Product Pipeline Analysis, 2014 Update

Date Published: Nov 14 2014

Summary

$750.00
MolecularMD, Corp. - Product Pipeline Analysis, 2014 Update

MolecularMD, Corp. - Product Pipeline Analysis, 2014 Update

Date Published: Nov 14 2014

Summary

$750.00
Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review

Date Published: Nov 3 2014

Torrent Pharmaceuticals Limited (TORNTPHARM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

$300.00
Dr. Falk Pharma GmbH - Product Pipeline Review - 2014

Dr. Falk Pharma GmbH - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Dr. Falk Pharma GmbH - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Dr. Falk Pharma GmbH - Product Pipeline Review - 2014’, provides an overview of the Dr. Falk Pharma GmbH’s pharmaceutical research and development focus.

$1,500.00
Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Provid Pharmaceuticals, Inc. - Product Pipeline Review - 2014’, provides an overview of the Provid Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

$1,500.00
Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Asklepios BioPharmaceutical, Inc. - Product Pipeline Review - 2014’, provides an overview of the Asklepios BioPharmaceutical, Inc.’s pharmaceutical research and development focus.

$1,500.00
Immunomic Therapeutics, Inc. - Product Pipeline Review - 2014

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Immunomic Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the Immunomic Therapeutics, Inc.’s pharmaceutical research and development focus.

$1,500.00
Altor BioScience Corporation - Product Pipeline Review - 2014

Altor BioScience Corporation - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Altor BioScience Corporation - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Altor BioScience Corporation - Product Pipeline Review - 2014’, provides an overview of the Altor BioScience Corporation’s pharmaceutical research and development focus.

$1,500.00
Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014

Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Reviva Pharmaceuticals Inc. - Product Pipeline Review - 2014’, provides an overview of the Reviva Pharmaceuticals Inc.’s pharmaceutical research and development focus.

$1,500.00
TransTech Pharma, Inc. - Product Pipeline Review - 2014

TransTech Pharma, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

TransTech Pharma, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘TransTech Pharma, Inc. - Product Pipeline Review - 2014’, provides an overview of the TransTech Pharma, Inc.’s pharmaceutical research and development focus.

$1,500.00
ProNAi Therapeutics, Inc. - Product Pipeline Review - 2014

ProNAi Therapeutics, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

ProNAi Therapeutics, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘ProNAi Therapeutics, Inc. - Product Pipeline Review - 2014’, provides an overview of the ProNAi Therapeutics, Inc.’s pharmaceutical research and development focus.

$1,500.00
CytImmune Sciences, Inc. - Product Pipeline Review - 2014

CytImmune Sciences, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

CytImmune Sciences, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘CytImmune Sciences, Inc. - Product Pipeline Review - 2014’, provides an overview of the CytImmune Sciences, Inc.’s pharmaceutical research and development focus.

$1,500.00
Apitope International NV - Product Pipeline Review - 2014

Apitope International NV - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Apitope International NV - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Apitope International NV - Product Pipeline Review - 2014’, provides an overview of the Apitope International NV’s pharmaceutical research and development focus.

$1,500.00
ImmunoBiology Ltd. - Product Pipeline Review - 2014

ImmunoBiology Ltd. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

ImmunoBiology Ltd. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘ImmunoBiology Ltd. - Product Pipeline Review - 2014’, provides an overview of the ImmunoBiology Ltd.’s pharmaceutical research and development focus.

$1,500.00
Lipopharma Therapeutics SL - Product Pipeline Review - 2014

Lipopharma Therapeutics SL - Product Pipeline Review - 2014

Date Published: Oct 30 2014

Lipopharma Therapeutics SL - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘Lipopharma Therapeutics SL - Product Pipeline Review - 2014’, provides an overview of the Lipopharma Therapeutics SL’s pharmaceutical research and development focus.

$1,500.00
CellAct Pharma GmbH - Product Pipeline Review - 2014

CellAct Pharma GmbH - Product Pipeline Review - 2014

Date Published: Oct 30 2014

CellAct Pharma GmbH - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘CellAct Pharma GmbH - Product Pipeline Review - 2014’, provides an overview of the CellAct Pharma GmbH’s pharmaceutical research and development focus.

$1,500.00
DEKK-TEC, Inc. - Product Pipeline Review - 2014

DEKK-TEC, Inc. - Product Pipeline Review - 2014

Date Published: Oct 30 2014

DEKK-TEC, Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct’s, ‘DEKK-TEC, Inc. - Product Pipeline Review - 2014’, provides an overview of the DEKK-TEC, Inc.’s pharmaceutical research and development focus.

$1,500.00

Pages

Shopping cart

0 Items $0.00
Not able to find what you are looking for?
Call Us
WHY CHOOSE MARKET RESEARCH REPORTS?
1
Trusted By Leaders
2
Shop With Confidence
3
Customer Centric
4
Personalized Solutions
5
Secure Checkout

User login

Clients Who Trust Us

Orange, Google, Microsoft, Barclays, CassidianIntel, TPG, Elit Net, Cross Business Producers, AcmavolpakB. Braun, Cobham, fiserv, Harris, Wipro, AonAl Meera, Nomura Research Institute, Tata Consultancy Services, Amara Raja, Hiranandani EnergyMunich Re, Lotte Chemical, National Post, First Data